Match Document Document Title
US20150210633 Process for the production of taurine from ethanol  
The present invention discloses a process for the preparation of taurine from ethionic acid and ethanol by way of ethanol-derived ethionic acid by the ammonolysis of ethionic acid and by the...
US20120041229 METHODS FOR MANUFACTURING TETRANOR-PROSTAGLANDIN D, J, E, A AND F METABOLITES  
The present invention generally relates to synthetic methods for preparing tetranor-prostaglandin D, J, E, A, and F metabolites.
US20110152166 METHOD OF MODULATION OF PROTEIN PHOSPHORYLATION-DEPENDENT CONFORMATIONAL TRANSITIONS WITH LOW MOLECULAR WEIGHT COMPOUNDS  
The present patent application discloses a method of identifying or validating a compound that modulates the phosphorylation-dependent activity of a target protein or protein complex, where the...
US20110257432 Metformin-Cysteine Prodrug  
A metformin-cysteine prodrug. It is believed that the prodrug of the present invention will transport in the LAT1 and LAT2 transporter system. Because the LAT1 and LAT2 transporters are important...
US20110009370 METHOD TO ENHANCE TISSUE REGENERATION  
The present invention provides for compositions and methods for modulating tissue growth using tissue growth modulators, which are agents that either enhance or inhibit tissue growth as desired by...
US20150038577 N-ACETYL L-CYSTEINE CHELATES AND METHODS FOR MAKING AND USING THE SAME  
A nutritional supplement for a human, the supplement having a chelate comprised of an N-acetyl-L-cysteine ligand bonded to a metal to form a chelate ring. A method for preparing a chelate...
US20120294866 PHARMACEUTICAL FORMULATION FOR PROTEINS  
The present invention provides a liquid pharmaceutical formulation comprising a therapeutic protein, a surfactant and at least an antioxidant selected from the group of radical scavengers,...
US20100305320 Polymorph, polymorph screening system, and polymorph preparing and screening method  
A polymorph, a polymorph screening system, and a polymorph preparing and screening method are disclosed. The polymorph preparing and screening method includes the following steps: providing a...
US20110009478 THERANOSTIC POLYCATION BEACONS COMPRISING OLIGOETHYLENEAMINE REPEATING UNITS AND LANTHANIDE CHELATES  
The present invention relates to vehicles for delivering macromolecules into cells. More particularly, embodiments of the invention relate to compounds and methods for binding and compacting...
US20140179014 FLUORESCENT NITRIC OXIDE PROBES AND ASSOCIATED METHODS  
Nitric oxide probes including a compound represented by Formula, I, II, III, IV, V, VI or a combination thereof are provided. Methods of using these nitric oxide probes to detect nitric oxide are...
US20130302903 FLUORESCENT NITRIC OXIDE PROBES AND ASSOCIATED METHODS  
Nitric oxide probes comprising a compound represented by Formula, I, II, III, IV, V, VI or a combination thereof are provided. Methods of using these nitric oxide probes to detect nitric oxide are...
US20110207962 PRODUCTION METHOD OF METHIONINE  
The present invention aims to provide a method of producing methionine by hydrolyzing M-hydantoin in the presence of a basic potassium compound, which can effectively prevent corrosion of reaction...
US20130211134 Process And System For The Separation of Solid Carboxylic Acid Fines  
In a process for the separation of solid carboxylic acid fines from mother liquor that includes such fines, the mother liquor is fed to a settlement drum at above atmospheric pressure. The mother...
US20110138888 TREATMENT OF OBESITY  
The present disclosure relates to the treatment, e.g. reduction, of body fat mass levels for example in overweight and obese subjects. The present disclosure also relates to weight control in a...
US20120197016 SCREENING METHODS OF MODULATING ADRENERGIC RECEPTOR GENE EXPRESSIONS IMPLICATED IN MELANOGENESIS  
Embodiments of screening methods for determining test agents effective for modifying the appearance of pigmented skin are provided. The screening method may comprise the steps of contacting a...
US20130091760 METHOD OF BIOBASED CHEMICAL PRODUCTION FROM CRUDE BIOGLYCERIN OF ANIMAL ORIGIN  
A method of production of value-added, biobased chemicals, derivative products, and/or purified glycerin from animal-based bioglycerin is described herein. A method of purification of animal-based...
US20150133442 METHODS AND COMPOSITIONS FOR THE INHIBITION OF PIN1  
The invention features compositions and methods for inhibiting the Pin1 protein, and the treatment of disorders characterized by elevated Pin1 levels.
US20120329744 Doxorubicin Adjuvants to Reduce Toxicity and Methods for Using the Same  
Methods are provided for using doxorubicin active agents in which reduced host toxicity is observed. Aspects of the methods including administering to a subject an effective amount of a...
US20110251426 SCREENING FOR SOLID FORMS BY ULTRASOUND CRYSTALLIZATION AND COCRYSTALLIZATION USING ULTRASOUND  
The present disclosure relates to crystallizing a chemical substance(s) using ultrasound. Methods are provided for screening a chemical substance according to its solid forms by using ultrasound...
US20150045389 COMPOUNDS AND METHODS FOR INHIBITING CIF VIRULENCE FACTOR  
The present invention is a screening assay for identifying inhibitors of Pseudomonas aeruginosa CFTR Inhibitory Factor as well as compounds identified by the screening assay for use in...
US20120059062 COMPOSITIONS COMPRISING CANNABINOIDS FOR TREATMENT OF NAUSEA, VOMITING, EMESIS, MOTION SICKNESS OR LIKE CONDITIONS  
Cannabinoids, in particular CBD and CBDA and their acid derivatives are provided for use as an active pharmaceutical substance in the treatment of nausea, vomiting, emesis, motion sickness. In...
US20110217721 WATER SOLUBLE FLUORESCENT QUANTUM CARBON DOTS  
The present invention relates to the water soluble self fluorescent quantum carbon dots (C-dots). These C-dots are isolated from carbon soot in one embodiment a wax soot solvent washed and...
US20100331570 METHOD FOR THE NITRATION OF SUBSTITUTED BENZENES IN THE PRESENCE OF PROPIONIC ACID  
The aim of the invention is to provide a widely applicable method for the nitration of substituted benzenes.
US20150053211 Cleaning and safe mouth guard solution  
An aqueous oral spray designed to treat mouth guards against bacterial infection comprising: 1. A naturally derived di-basic amino acid derivative,2. A natural sweetener which inhibits the...
US20120041178 Coenzyme Q10 Nanoparticles, Preparation Method Thereof and Composition Containing Said Nanoparticles  
Provided are a coenzyme Q10 nanoparticle, a method of preparing the same and a composition having the nanoparticle. According to the present invention, Coenzyme Q10 may be dissolved in only a...
US20150159078 LOW INTERFACIAL TENSION SURFACTANTS FOR PETROLEUM APPLICATIONS  
The invention relates to a class of novel surfactants that have utility in the recovery and/or extraction of oil.
US20140346089 LOW INTERFACIAL TENSION SURFACTANTS FOR PETROLEUM APPLICATIONS  
The invention relates to a class of novel surfactants that have utility in the recovery and/or extraction of oil.
US20140057816 LOW INTERFACIAL TENSION SURFACTANTS FOR PETROLEUM APPLICATIONS  
The invention relates to a class of novel surfactants that have utility in the recovery and/or extraction of oil.
US20130274156 LOW INTERFACIAL TENSION SURFACTANTS FOR PETROLEUM APPLICATIONS  
The invention relates to a class of novel surfactants that have utility in the recovery and/or extraction of oil.
US20110309001 LOW INTERFACIAL TENSION SURFACTANTS FOR PETROLEUM APPLICATIONS  
The invention relates to a class of novel surfactants that have utility in the recovery and/or extraction of oil.
US20110065612 LOW INTERFACIAL TENSION SURFACTANTS FOR PETROLEUM APPLICATIONS  
The invention relates to a class of novel surfactants that have utility in the recovery and/or extraction of oil.
US20120209026 METHOD FOR PRODUCING A CARNOSIC ACID-RICH PLANT EXTRACT  
A carnosic acid-rich plant extract can be produced by extracting a dried and comminuted plant material containing carnosic acid with supercritical CO2 at a pressure of at least 200 bar and at a...
US20150232438 PROCESS FOR IMPROVED SEAWEED BIOMASS CONVERSION FOR FUEL INTERMEDIATES, AGRICULTURAL NUTRIENTS AND FRESH WATER  
The invention relates to an integrated process for the production of 5-hydroxymethyl furfural (HMF), K2SO4, levulinic acid and formic acid from κ-carrageenan, the latter being obtained from fresh...
US20100323005 Sodium Ibuprofen Tablets and Methods of Manufacturing Pharmaceutical Compositions Including Sodium Ibuprofen  
Sodium ibuprofen compositions and methods of manufacturing tablets and caplets comprising sodium ibuprofen are described. The formulation is advantageous because it allows for the formation of...
US20150250748 COMPOSITIONS FOR USE IN SURGERY  
A method is provided for treating a subject in need of medication as an adjunct to elective surgery, comprising administration of a ketogenic material sufficient to produce a physiologically...
US20140243410 COMPOSITIONS FOR USE IN SURGERY  
A method is provided for treating a subject in need of medication as an adjunct to elective surgery, comprising administration of a ketogenic material sufficient to produce a physiologically...
US20110237831 PROCESSES FOR PRODUCING MONOAMMONIUM SUCCINATE FROM FERMENTATION BROTHS CONTAINING DIAMMONIUM SUCCINATE, MONOAMMONIUM SUCCINATE AND/OR SUCCINIC ACID, AND CONVERSION OF MONOAMMONIUM SUCCINATE TO SUCCINIC ACID  
Processes for making monoammonium succinate (MAS) and/or succinic acid (SA) from either a clarified diammonium succinate (DAS)-containing fermentation broth or a clarified MAS-containing...
US20140309454 METHODS FOR THE VALORIZATION OF CARBOHYDRATES  
There are provided methods for the valorization of carbohydrates. The methods comprise reacting a fluid comprising at least one carbohydrate with at least one metal catalyst or at least one metal...
US20090317341 Compositions for Lightening Skin Color  
Skin lightening additives and skin lightening compositions having at least one of a heterosubstituted, saturated or unsaturated aliphatic acid are described. The compositions are suitable for...
US20120209003 METHODS FOR IDENTIFYING AND USING MarR FAMILY POLYPEPTIDE BINDING COMPOUNDS  
Methods for identifying MarR family inhibiting compounds are described. The methods include the use of computer aided rational based drug design programs and three dimensional structures of MarR...
US20110015375 Methods for Identifying and Using MarR Family Polypeptide Binding Compounds  
Methods for identifying MarR family inhibiting compounds are described. The methods include the use of computer aided rational based drug design programs and three dimensional structures of MarR...
US20110311505 Photosensitive Aminoacid-Monomer Linkage and Bioconjugation Applications in Life Sciences and Biotechnology  
This invention is related to preparation of photosensitive ruthenium based aminoacid monomers and oligomers, aminoacid monomer-protein cross-linking using photo sensitat ion and conjugation on...
US20110082176 Stilbenes and Chalcones for the Prevention and Treatment of Cardiovascular Diseases  
The present disclosure provides non-naturally occurring polyphenol compounds that upregulate the expression of Apolipoprotein A-I (ApoA-I). The disclosed compositions and methods can be used for...
US20130136809 7-HYRDROXYFRULLANOLIDE ITS ANALOGS FOR PREVENTION CONTROL AND TREATMENT OF METABOLIC DISORDERS  
The invention discloses biologically active ingredient(s) selected from 7-hydroxyfrullanolide, its analogs, the ex-tract(s) and fraction(s) standardized to 7-hydroxyfrullanolide or its analogs or...
US20150079001 IMAGING AGENTS AND METHODS OF IMAGING NAALADASE OR PSMA  
The present invention relates to compounds particularly asymmetric urea compounds which are labeled with one or more radioisotopes and which are suitable for imaging or therapeutic treatment of...
US20120276007 IMAGING AGENTS AND METHODS OF IMAGING NAALADASE OR PSMA  
The present invention relates to compounds particularly asymmetric urea compounds which are labeled with one or more radioisotopes and which are suitable for imaging or therapeutic treatment of...
US20120225938 METHOD FOR TREATING CENTRAL NERVOUS SYSTEM DISORDERS  
The present invention provides a method for treating a central nervous system disorder in a mammalian subject, which comprises administering an effective amount of a 11-deoxy-prostaglandin...
US20150246037 TREATMENT FOR NEURODEGENERATION  
Provided is a method of treating and/or preventing Wolfram Syndrome (WS)-related neurodegeneration (i.e. of Wolfram Syndrome-Associated Neuronal Degeneration), by increasing the expression and/or...
US20120296117 METHODS FOR PRODUCTION OF HIGH CONCENTRATION OF ARGININE BICARBONATE SOLUTION AT HIGH PRESSURE  
Methods of producing arginine bicarbonate solutions in very high concentrations including reacting an arginine slurry containing a first portion of arginine with a source of carbon dioxide gas at...
US20120259127 PROCESS FOR THE RESOLUTION OF ENANTIOMERS BY PREFERENTIAL EVAPORATIVE CRYSTALLIZATION  
A process for the resolution of two enantiomers which involves inducing the preferential crystallization of one enantiomer by adjusting the composition of a suspension or solution including a...